Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,143,908

« Back to Dashboard
Patent 7,143,908 protects FLOVENT HFA, ADVAIR HFA, and VENTOLIN HFA, and is included in three NDAs.

Protection for FLOVENT HFA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 7,143,908

Title:Indicating device
Abstract:A device for dispensing metered dosages of a substance from a container includes a dispenser housing having a longitudinally extending cavity defined at least in part by a wall and a support block spaced from the wall. The container is disposed in the cavity of the dispenser housing and is container reciprocally moveable within the dispenser housing along a longitudinal axis. An indicating device is disposed in the dispenser housing and includes an annular member disposed around a first end of the container with a valve stem of the container extending beyond the annular member. The indicating device includes at least one indicator member rotatable about an axis of rotation. At least a portion of the indicating device is fixedly connected to the container and is reversibly removable with the container from the dispenser housing.
Inventor(s): Blacker; Richard (London, CA), Engelbreth; Daniel K. (London, CA), Schmidt; James N. (London, CA)
Assignee: Trudell Medical International (London, CA)
Application Number:11/372,441
Patent Claim Types:
see list of patent claims
Device; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Handling
Back Citations: 12th percentile
Forward Citations: 2nd percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-003May 14, 2004RXYes7,143,908*PEDJul 16, 2018Y
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-002May 14, 2004RXYes7,143,908*PEDJul 16, 2018Y
Glaxo Grp Ltd
fluticasone propionate
AEROSOL, METERED;INHALATION021433-001May 14, 2004RXYes7,143,908*PEDJul 16, 2018Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.